Chargement en cours...

Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss

Multiple myeloma (MM) is a plasma cell malignancy, characterized by osteolytic lesions and monoclonal immunoglobulins. The anemia, accompanying the disease is often treated with recombinant human EPO. Diverse non-erythropoietic effects of EPO have led us to question its combined action on the immune...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Deshet-Unger, Naamit, Hiram-Bab, Sahar, Haim-Ohana, Yasmin, Mittelman, Moshe, Gabet, Yankel, Neumann, Drorit
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4969594/
https://ncbi.nlm.nih.gov/pubmed/27481313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep30998
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!